Inhibition of proliferation and induction of differentiation in medulloblastoma- and astrocytoma-derived cell lines with phenylacetate

View More View Less
  • 1 Cotzias Laboratory of Neuro-Oncology and Departments of Neurology and Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York; and Clinical Pharmacology Branch, Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
Print or Print + Online

✓ The authors investigated the effects of a nontoxic differentiation inducer, phenylacetate (PA), on neuroectodermal tumor—derived cell lines. Treatment of medulloblastoma (Daoy and D283 MED) and glioma (U-251MG, C6, and RG2) cell lines resulted in a dose-dependent decline in DNA synthesis and cell proliferation, associated with accumulation in the G0/G1 phase of the cell cycle. Phenylacetate decreased transforming growth factor (TGF)—β2 production by medulloblastoma Daoy cells. Neutralizing antibodies against either TGFβ2 or TGFβ1 failed to block the growth arrest observed. This suggests that, unlike other differentiation agents, such as retinoic acid, the effect of PA on medulloblastoma proliferation is not mediated by a TGFβ pathway. In addition to cytostasis, PA induced marked morphological changes in U-251MG and C6 glioma cells associated with increased abundance of glial fibrillary acidic protein—positive processes. Although the morphology of PA-treated medulloblastoma cells was not significantly altered, the D283 MED cells exhibited increased expression of neurofilament proteins and Hu antigen, indicative of differentiation along a neuronal pathway. The effects of PA on the medulloblastoma cell lines were compared to its effects on the human neuroblastoma cell line BE(2)C, which is capable of a bidirectional differentiation toward a neuronal or a glial/schwann cell pathway. In BE(2)C cells, PA induced differentiation toward a schwann/glial cell-like phenotype, suggesting that the choice of differentiation pathway is cell type and agent specific. These in vitro antiproliferative and differentiation inducing effects of PA suggest that this agent warrants further evaluation as a potential therapeutic modality for the treatment of medulloblastoma and malignant glioma in humans.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
  • 1.

    Agrawal A, , Martell LA, & Ross DA, et al: Retinoic acid modulation of proliferation and differentiation in brain tumors. Proc Am Assoc Cancer Res 34:20, 1993 (Abstract) Agrawal A, Martell LA, Ross DA, et al: Retinoic acid modulation of proliferation and differentiation in brain tumors. Proc Am Assoc Cancer Res 34:20, 1993 (Abstract)

    • Search Google Scholar
    • Export Citation
  • 2.

    Baker DL, , Reddy UR, & Pleasure S, et al: Human central nervous system primitive neuroectodermal tumor expressing nerve growth factor receptors: CHP707m. Ann Neurol 28:136145, 1990 Baker DL, Reddy UR, Pleasure S, et al: Human central nervous system primitive neuroectodermal tumor expressing nerve growth factor receptors: CHP707m. Ann Neurol 28:136–145, 1990

    • Search Google Scholar
    • Export Citation
  • 3.

    Biedler JL, , Casals D, & Chang T, et al: Multidrug resistant human neuroblastoma cells are more differentiated than controls and retinoic acid further induces lineage-specific differentiation. Adv Neuroblastoma Res 3:181191, 1991 Biedler JL, Casals D, Chang T, et al: Multidrug resistant human neuroblastoma cells are more differentiated than controls and retinoic acid further induces lineage-specific differentiation. Adv Neuroblastoma Res 3:181–191, 1991

    • Search Google Scholar
    • Export Citation
  • 4.

    Brusilow SW, , Danney M, & Waber LJ, et al: Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis. N Engl J Med 310:16301634, 1984 Brusilow SW, Danney M, Waber LJ, et al: Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis. N Engl J Med 310:1630–1634, 1984

    • Search Google Scholar
    • Export Citation
  • 5.

    Budde-Steffen C, , Anderson NE, & Rosenblum MK, et al: Expression of an antigen in small cell lung carcinoma lines detected by antibodies from patients with paraneoplastic dorsal root gangliopathy. Cancer Res 48:430434, 1988 Budde-Steffen C, Anderson NE, Rosenblum MK, et al: Expression of an antigen in small cell lung carcinoma lines detected by antibodies from patients with paraneoplastic dorsal root gangliopathy. Cancer Res 48:430–434, 1988

    • Search Google Scholar
    • Export Citation
  • 6.

    Ciccarone V, , Spengler BA, & Meyers MB, et al: Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res 49:219225, 1989 Ciccarone V, Spengler BA, Meyers MB, et al: Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res 49:219–225, 1989

    • Search Google Scholar
    • Export Citation
  • 7.

    Clark WC, & Bressler J: Transforming growth factor-β-like activity in tumors of the central nervous system. J Neurosurg 68:920924, 1988 Clark WC, Bressler J: Transforming growth factor-β-like activity in tumors of the central nervous system. J Neurosurg 68:920–924, 1988

    • Search Google Scholar
    • Export Citation
  • 8.

    Coffin CM, , Braun JT, & Wick MR, et al: A clinicopathologic and immunohistochemical analysis of 53 cases of medulloblastoma with emphasis on synaptophysin expression. Mod Pathol 3:164170, 1990 Coffin CM, Braun JT, Wick MR, et al: A clinicopathologic and immunohistochemical analysis of 53 cases of medulloblastoma with emphasis on synaptophysin expression. Mod Pathol 3:164–170, 1990

    • Search Google Scholar
    • Export Citation
  • 9.

    Dalmau J, , Furneaux HM, & Cordon-Cardo C, et al: The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am J Pathol 141:881886, 1992 Dalmau J, Furneaux HM, Cordon-Cardo C, et al: The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am J Pathol 141:881–886, 1992

    • Search Google Scholar
    • Export Citation
  • 10.

    Dalmau J, , Furneaux HM, & Gralla RJ, et al: Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer—a quantitative Western blot analysis. Ann Neurol 27:544552, 1990 Dalmau J, Furneaux HM, Gralla RJ, et al: Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer—a quantitative Western blot analysis. Ann Neurol 27:544–552, 1990

    • Search Google Scholar
    • Export Citation
  • 11.

    De Chadarévian JP, , Montes JL, & O'Gorman AM, et al: Maturation of cerebellar neuroblastoma into ganglioneuroma with melanosis. A histologic, immunocytochemical, and ultrastructural study. Cancer 59:6976, 1987 De Chadarévian JP, Montes JL, O'Gorman AM, et al: Maturation of cerebellar neuroblastoma into ganglioneuroma with melanosis. A histologic, immunocytochemical, and ultrastructural study. Cancer 59:69–76, 1987

    • Search Google Scholar
    • Export Citation
  • 12.

    Dover GJ, , Brusilow S, & Samid D: Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate. N Engl J Med 327:569570, 1992 Dover GJ, Brusilow S, Samid D: Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate. N Engl J Med 327:569–570, 1992

    • Search Google Scholar
    • Export Citation
  • 13.

    Falk LA, , De Benedetti F, & Lohrey N, et al: Induction of transforming growth factor-β1 (TGF-β1) receptor expression and TGF-β1 protein production in retinoic acid-treated HL-60 cells: possible TGF-β1-mediated autocrine inhibition. Blood 77:12481255, 1991 Falk LA, De Benedetti F, Lohrey N, et al: Induction of transforming growth factor-β1 (TGF-β1) receptor expression and TGF-β1 protein production in retinoic acid-treated HL-60 cells: possible TGF-β1-mediated autocrine inhibition. Blood 77:1248–1255, 1991

    • Search Google Scholar
    • Export Citation
  • 14.

    Graus F, , Elkon KB, & Cordon-Cardo C, et al: Sensory neuronopathy and small cell lung cancer: antineuronal antibody that also reacts with the tumor. Am J Med 80:4552, 1986 Graus F, Elkon KB, Cordon-Cardo C, et al: Sensory neuronopathy and small cell lung cancer: antineuronal antibody that also reacts with the tumor. Am J Med 80:45–52, 1986

    • Search Google Scholar
    • Export Citation
  • 15.

    He X, , Skapek SX, & Wikstrand CJ, et al: Phenotypic analysis of four human medulloblastoma cell lines and transplantable xenografts. J Neuropathol Exp Neurol 48:4868, 1989 He X, Skapek SX, Wikstrand CJ, et al: Phenotypic analysis of four human medulloblastoma cell lines and transplantable xenografts. J Neuropathol Exp Neurol 48:48–68, 1989

    • Search Google Scholar
    • Export Citation
  • 16.

    Hsu SM, , Raine L, & Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577580, 1981 Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577–580, 1981

    • Search Google Scholar
    • Export Citation
  • 17.

    Jacobsen PF, , Jenkyn DJ, & Papadimitriou JM: Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice. J Neuropathol Exp Neurol 44:472495, 1985 Jacobsen PF, Jenkyn DJ, Papadimitriou JM: Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice. J Neuropathol Exp Neurol 44:472–495, 1985

    • Search Google Scholar
    • Export Citation
  • 18.

    James MO, , Smith RL, & Williams RT, et al: The conjugation of phenylacetic acid in man, sub-human primates and some nonprimate species. Proc R Soc Lond Biol Sci 182:2535, 1972 James MO, Smith RL, Williams RT, et al: The conjugation of phenylacetic acid in man, sub-human primates and some nonprimate species. Proc R Soc Lond Biol Sci 182:25–35, 1972

    • Search Google Scholar
    • Export Citation
  • 19.

    Jennings MT, , Maciunas RJ, & Carver R, et al: TGFβ1 and TGFβ2 are potential growth regulators for low-grade and malignant gliomas in vitro: evidence in support of an autocrine hypothesis. Int J Cancer 49:129139, 1991 Jennings MT, Maciunas RJ, Carver R, et al: TGFβ1 and TGFβ2 are potential growth regulators for low-grade and malignant gliomas in vitro: evidence in support of an autocrine hypothesis. Int J Cancer 49:129–139, 1991

    • Search Google Scholar
    • Export Citation
  • 20.

    Lee MY, & Andrews PW: Differentiation of NTERA-2 clonal human embryonal carcinoma cells into neurons involves the induction of all three neurofilament proteins. J Neurosci 6:514521, 1986 Lee MY, Andrews PW: Differentiation of NTERA-2 clonal human embryonal carcinoma cells into neurons involves the induction of all three neurofilament proteins. J Neurosci 6:514–521, 1986

    • Search Google Scholar
    • Export Citation
  • 21.

    Lieberman F, , Finzi D, & Ferro J: Retinoic acid decreases proliferation and Hu expression in medulloblastoma cells. Ann Neurol 32:286, 1992 (Abstract) Lieberman F, Finzi D, Ferro J: Retinoic acid decreases proliferation and Hu expression in medulloblastoma cells. Ann Neurol 32:286, 1992 (Abstract)

    • Search Google Scholar
    • Export Citation
  • 22.

    Lipsky RH, & Silverman SJ: Effects of mycophenolic acid on detection of glial filaments in human and rat astrocytoma cultures. Cancer Res 47:49004904, 1987 Lipsky RH, Silverman SJ: Effects of mycophenolic acid on detection of glial filaments in human and rat astrocytoma cultures. Cancer Res 47:4900–4904, 1987

    • Search Google Scholar
    • Export Citation
  • 23.

    Marks PA, , Sheffery M, & Rifkind RA: Induction of transformed cells to terminal differentiation and the modulation of gene expression. Cancer Res 47:659666, 1987 Marks PA, Sheffery M, Rifkind RA: Induction of transformed cells to terminal differentiation and the modulation of gene expression. Cancer Res 47:659–666, 1987

    • Search Google Scholar
    • Export Citation
  • 24.

    Marusich MF, & Weston JA: Identification of early neurogenic cells in the neural crest lineage. Dev Biol 149:295306, 1992 Marusich MF, Weston JA: Identification of early neurogenic cells in the neural crest lineage. Dev Biol 149:295–306, 1992

    • Search Google Scholar
    • Export Citation
  • 25.

    Molenaar WM, , Baker DL, & Pleasure D, et al: The neuroendocrine and neural profiles of neuroblastomas, ganglioneuroblastomas, and ganglioneuromas. Am J Pathol 136:375382, 1990 Molenaar WM, Baker DL, Pleasure D, et al: The neuroendocrine and neural profiles of neuroblastomas, ganglioneuroblastomas, and ganglioneuromas. Am J Pathol 136:375–382, 1990

    • Search Google Scholar
    • Export Citation
  • 26.

    Molenaar WM, , Jansson DS, & Gould VE, et al: Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors. Lab Invest 61:635643, 1989 Molenaar WM, Jansson DS, Gould VE, et al: Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors. Lab Invest 61:635–643, 1989

    • Search Google Scholar
    • Export Citation
  • 27.

    Pleasure SJ, , Page C, & Lee VMY: Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci 12:18031805, 1992 Pleasure SJ, Page C, Lee VMY: Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci 12:1803–1805, 1992

    • Search Google Scholar
    • Export Citation
  • 28.

    Ram Z, , Samid D, & Walbridge S, et al: Growth inhibition, tumor maturation, and extended survival in experimental brain tumors in rats treated with phenylacetate. Cancer Res 54:29232927, 1994 Ram Z, Samid D, Walbridge S, et al: Growth inhibition, tumor maturation, and extended survival in experimental brain tumors in rats treated with phenylacetate. Cancer Res 54:2923–2927, 1994

    • Search Google Scholar
    • Export Citation
  • 29.

    Ross RA, , Bossart E, & Spengler BA, et al: Multipotent capacity of morphologically intermediate (I-type) human neuroblastoma cells after treatment with differentiation-inducing drugs. Adv Neuroblastoma Res 3:193201, 1991 Ross RA, Bossart E, Spengler BA, et al: Multipotent capacity of morphologically intermediate (I-type) human neuroblastoma cells after treatment with differentiation-inducing drugs. Adv Neuroblastoma Res 3:193–201, 1991

    • Search Google Scholar
    • Export Citation
  • 30.

    Ross RA, , Spengler BA, & Rettig WR, et al: Permanent phenotypic conversion of human neuroblastoma I-type cells. Proc Am Assoc Cancer Res 34:44, 1993 (Abstract) Ross RA, Spengler BA, Rettig WR, et al: Permanent phenotypic conversion of human neuroblastoma I-type cells. Proc Am Assoc Cancer Res 34:44, 1993 (Abstract)

    • Search Google Scholar
    • Export Citation
  • 31.

    Rutka JT, , De Armond SJ, & Giblin J, et al: Effect of retinoids on the proliferation, morphology and expression of glial fibrillary acidic protein of an anaplastic astrocytoma cell line. Int J Cancer 42:419427, 1988 Rutka JT, De Armond SJ, Giblin J, et al: Effect of retinoids on the proliferation, morphology and expression of glial fibrillary acidic protein of an anaplastic astrocytoma cell line. Int J Cancer 42:419–427, 1988

    • Search Google Scholar
    • Export Citation
  • 32.

    Samid D, , Ram Z, & Hudgins WR, et al: Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria. Cancer Res 54:891895, 1994 Samid D, Ram Z, Hudgins WR, et al: Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria. Cancer Res 54:891–895, 1994

    • Search Google Scholar
    • Export Citation
  • 33.

    Samid D, , Shack S, & Myers CE: Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate. J Clin Invest 91:22882295, 1993 Samid D, Shack S, Myers CE: Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate. J Clin Invest 91:2288–2295, 1993

    • Search Google Scholar
    • Export Citation
  • 34.

    Samid D, , Shack S, & Sherman LT: Phenylacetate: a novel nontoxic inducer of tumor cell differentiation. Cancer Res 52:19881992, 1992 Samid D, Shack S, Sherman LT: Phenylacetate: a novel nontoxic inducer of tumor cell differentiation. Cancer Res 52:1988–1992, 1992

    • Search Google Scholar
    • Export Citation
  • 35.

    Samid D, , Yeh A, & Prasanna P: Induction of erythroid differentiation and fetal hemoglobin production in human leukemic cells treated with phenylacetate. Blood 80:15761581, 1992 Samid D, Yeh A, Prasanna P: Induction of erythroid differentiation and fetal hemoglobin production in human leukemic cells treated with phenylacetate. Blood 80:1576–1581, 1992

    • Search Google Scholar
    • Export Citation
  • 36.

    Samuels V, , Barrett JM, & Bockman S, et al: Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas. Am J Pathol 134:895902, 1989 Samuels V, Barrett JM, Bockman S, et al: Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas. Am J Pathol 134:895–902, 1989

    • Search Google Scholar
    • Export Citation
  • 37.

    Sartorelli AC: Malignant cell differentiation as a potential therapeutic approach. Br J Cancer 52:293302, 1985 Sartorelli AC: Malignant cell differentiation as a potential therapeutic approach. Br J Cancer 52:293–302, 1985

    • Search Google Scholar
    • Export Citation
  • 38.

    Schofield DE: Diagnostic histopathology, cytogenetics, and molecular markers of pediatric brain tumors. Neurosurg Clin North Am 3:723738, 1992 Schofield DE: Diagnostic histopathology, cytogenetics, and molecular markers of pediatric brain tumors. Neurosurg Clin North Am 3:723–738, 1992

    • Search Google Scholar
    • Export Citation
  • 39.

    Siepl C, , Bodmer S, & Frei K, et al: The glioblastoma-derived T cell suppressor factor/transforming growth factor-β2 inhibits T cell growth without affecting the interaction of interleukin 2 with its receptor. Eur J Immunol 18:593600, 1988 Siepl C, Bodmer S, Frei K, et al: The glioblastoma-derived T cell suppressor factor/transforming growth factor-β2 inhibits T cell growth without affecting the interaction of interleukin 2 with its receptor. Eur J Immunol 18:593–600, 1988

    • Search Google Scholar
    • Export Citation
  • 40.

    Sporn MB, & Roberts AB: Interactions of retinoids and transforming growth factor-beta in regulation of cell differentiation and proliferation. Mol Endocrinol 5:37, 1991 Sporn MB, Roberts AB: Interactions of retinoids and transforming growth factor-beta in regulation of cell differentiation and proliferation. Mol Endocrinol 5:3–7, 1991

    • Search Google Scholar
    • Export Citation
  • 41.

    Szabo A, , Dalmau J, & Manley G, et al: HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 67:325333, 1991 Szabo A, Dalmau J, Manley G, et al: HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 67:325–333, 1991

    • Search Google Scholar
    • Export Citation
  • 42.

    Tapscott SJ, , Bennett GS, & Holtzer H: Neuronal precursor cells in the chick neural tube express neurofilament proteins. Nature 292:836838, 1981 Tapscott SJ, Bennett GS, Holtzer H: Neuronal precursor cells in the chick neural tube express neurofilament proteins. Nature 292:836–838, 1981

    • Search Google Scholar
    • Export Citation
  • 43.

    Thibault A, , Cooper MR, & Figg MD, et al: A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer. Cancer Res 54:16901694, 1994 Thibault A, Cooper MR, Figg MD, et al: A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer. Cancer Res 54:1690–1694, 1994

    • Search Google Scholar
    • Export Citation
  • 44.

    Tremblay FG, , Lee VMY, & Trojanowski JQ: Expression of vimentin, glial filament, and neurofilament proteins in primitive childhood brain tumors. A comparative immunoblot and immunoperoxidase study. Acta Neuropathol 68:239244, 1985 Tremblay FG, Lee VMY, Trojanowski JQ: Expression of vimentin, glial filament, and neurofilament proteins in primitive childhood brain tumors. A comparative immunoblot and immunoperoxidase study. Acta Neuropathol 68:239–244, 1985

    • Search Google Scholar
    • Export Citation
  • 45.

    Trojanowski JQ, , Friedman HS, & Burger PC, et al: A rapidly dividing human medulloblastoma cell line (D283 MED) expresses all three neurofilament subunits. Am J Pathol 126:358363, 1987 Trojanowski JQ, Friedman HS, Burger PC, et al: A rapidly dividing human medulloblastoma cell line (D283 MED) expresses all three neurofilament subunits. Am J Pathol 126:358–363, 1987

    • Search Google Scholar
    • Export Citation
  • 46.

    Vaniushin BF, , Bashkite EA, & Fridrikh A, et al: Metilirovanie DNK prorostkakh pshenitsy i vliianie fitogormonov. Biokhimiya 46:4754, 1981 Vaniushin BF, Bashkite EA, Fridrikh A, et al: Metilirovanie DNK prorostkakh pshenitsy i vliianie fitogormonov. Biokhimiya 46:47–54, 1981

    • Search Google Scholar
    • Export Citation
  • 47.

    Younkin DP, , Tang CM, & Hardy M, et al: Inducible expression of neuronal glutamate receptor channels in the NT2 human cell line. Proc Natl Acad Sci (USA) 90:21742178, 1993 Younkin DP, Tang CM, Hardy M, et al: Inducible expression of neuronal glutamate receptor channels in the NT2 human cell line. Proc Natl Acad Sci (USA) 90:2174–2178, 1993

    • Search Google Scholar
    • Export Citation
  • 48.

    Yung WKA, , Lotan R, & Lee P, et al: Modulation of growth and epidermal growth factor receptor activity by retinoic acid in human glioma cells. Cancer Res 49:10141019, 1989 Yung WKA, Lotan R, Lee P, et al: Modulation of growth and epidermal growth factor receptor activity by retinoic acid in human glioma cells. Cancer Res 49:1014–1019, 1989

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 363 98 10
Full Text Views 176 1 0
PDF Downloads 95 1 0
EPUB Downloads 0 0 0